Tag: T-DXd
HER2-Positive Breast Cancer: Targeted Therapies Explained
HER2-positive breast cancer is no longer a death sentence. Targeted therapies like trastuzumab, T-DXd, and tucatinib have transformed outcomes, offering longer survival and better quality of life. Learn how these drugs work and what’s next.